Research | Page 14 of 638 | SpiritIndia.com

Pancreatitis :: Large dose dexamethasone plays important roles in severe acute pancreatitis

Severe acute pancreatitis (SAP) is a fatal systemic disease featuring acute onset, serious conditions, high incidence of complications and 20 – 30% mortality, mainly due to multiple organ failure at its early stage. The pathogenesis of SAP is closely related to factors such as activation of pancreatin, release of inflammatory mediators, microcirculation disturbance and apoptosis.

Colorectal Cancer :: Does neural cell adhesion molecule-180 predict survival in colorectal cancer?

When a person learns they are suffering from cancer, the first question in their mind is always: “How much time do I have?” Unfortunately, this is a question to which the researchers have long been seeking an absolute answer. Tumor progression to local invasion and metastasis are the most relevant processes for prognosis, and predictive factors for survival are sometimes the only hope for cancer patients. Tumor suppressors and adhesion molecules represent one of the primary challenges in cancer therapy.

Hepatitis C :: 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus

Patients with the hepatitis C virus (HCV) have a risk of frequent recurrence and deterioration of liver function, even after curative treatment for the primary hepatocellular carcinoma (HCC). This unfavorable prognosis is associated with a sustained HCV infection. Thus, both the prevention of HCC recurrence and the preservation of liver function are high priorities when trying to improve the prognosis of patients with HCV-related HCC. Antiviral therapy for chronic hepatitis C (HCV) after treatment for primary HCC is the essential factor required for an improved prognosis.

Prostate Cancer :: Men, don’t skip your prostate cancer treatment appointments!

Men with “low risk” prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1,800 patients treated at Fox Chase Cancer Center in Philadelphia. The results were presented today at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.

Heart Disease :: Link between pre-eclampsia and heart disease

Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.

HIV :: HIV-TB spreads in Africa, undermines control of world’s 2 deadliest infectious diseases

The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.

Diabetes :: Stanford researchers shed light on gestational diabetes

A protein in the pancreas is giving researchers at the Stanford University School of Medicine their first chance at cracking the code that determines how diabetes develops during pregnancy, a finding that could lead to new treatments for all forms of diabetes.

Liver Cancer :: Radio waves fire up nanotubes embedded in tumors, destroying liver cancer

Cancer cells treated with carbon nanotubes can be destroyed by non-invasive radio waves that heat up the nanotubes while sparing untreated tissue, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center and Rice University has shown in preclinical experiments.

Folic Acid :: Scientists question folic acid fortification

Scientists at the Institute of Food Research have highlighted possible consequences of fortifying flour with folic acid due to new evidence of how it is absorbed by the body.

Prostate Cancer :: Radiation after surgery keeps high-risk prostate cancer at bay

An analysis of data involving more than 2,000 patients from 17 U.S. institutions demonstrates that men with high-risk prostate cancer who receive radiation therapy after a prostatectomy were less likely to have a recurrence of disease. What’s more, men whose cancer persists after surgery were less likely to see the cancer spread if they receive radiation (salvage therapy). These are the conclusions of a study presented today at the American Society for Therapeutic Radiology and Oncology’s 49th Annual Meeting in Los Angeles.